Tau protein seems not to be a useful routine clinical marker of axonal damage in multiple sclerosis

Background The descriptions of early axonal damage in patients with multiple sclerosis (MS) prompted the search of body fluid markers. However, the studies addressing this issue in MS present conflicting results. Aim To assess the levels of tau protein in patients with definite MS. Patients and meth...

Ausführliche Beschreibung